Rankings
▼
Calendar
RCKT Q2 2025 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$572M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$71M
Net Income
-$69M
EPS (Diluted)
$-0.62
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$49M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$421M
Total Liabilities
$67M
Stockholders' Equity
$354M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$2M
+100.0%
Operating Income
-$71M
-$74M
+3.5%
Net Income
-$69M
-$70M
+1.0%
← FY 2025
All Quarters
Q3 2025 →